SINGLE PATIENT FOCUS Trademark

Trademark Overview

On Thursday, December 1, 2022, a trademark application was filed for SINGLE PATIENT FOCUS with the United States Patent and Trademark Office. The USPTO has given the SINGLE PATIENT FOCUS trademark a serial number of 97700269. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Wednesday, December 13, 2023. This trademark is owned by Dramatic Change Ltd. The SINGLE PATIENT FOCUS trademark is filed in the Education & Entertainment Services category with the following description:

Educational services, namely, conducting classes, conferences, seminars and workshops and providing of training in the area of the sales and marketing of pharmaceutical products and related goods
single patient focus

General Information

Serial Number97700269
Word MarkSINGLE PATIENT FOCUS
Filing DateThursday, December 1, 2022
Status616 - REVIVED - AWAITING FURTHER ACTION
Status DateWednesday, December 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesEducational services, namely, conducting classes, conferences, seminars and workshops and providing of training in the area of the sales and marketing of pharmaceutical products and related goods

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, December 5, 2022
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDramatic Change Ltd
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressLondon SW152SH
GB

Trademark Events

Event DateEvent Description
Monday, December 5, 2022NEW APPLICATION ENTERED
Monday, December 5, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 11, 2023ASSIGNED TO EXAMINER
Monday, September 11, 2023NON-FINAL ACTION WRITTEN
Monday, September 11, 2023NON-FINAL ACTION E-MAILED
Monday, September 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 13, 2023TEAS PETITION TO REVIVE RECEIVED
Wednesday, December 13, 2023PETITION TO REVIVE-GRANTED
Wednesday, December 13, 2023NOTICE OF REVIVAL - E-MAILED
Wednesday, December 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 13, 2023NOTICE OF REVIVAL - E-MAILED
Friday, May 3, 2024ASSIGNED TO LIE
Friday, May 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

focus patient single marketing sales area pharmaceutical products goods related training providing conducting